Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined Vaccine

NCT00406211 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

398

Enrollment

INDUSTRY

Sponsor class

Conditions

Rubella
Varicella
Mumps
Measles

Interventions

BIOLOGICAL: MMRV
BIOLOGICAL: MMR (Priorix®)
BIOLOGICAL: Varicella (Varilrix®)

Sponsor

GlaxoSmithKline